Blackstone Inc Compass Therapeutics, Inc. Transaction History
Blackstone Inc
- $20.9 Billion
- Q2 2025
A detailed history of Blackstone Inc transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Blackstone Inc holds 10,025,151 shares of CMPX stock, worth $31.8 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
10,025,151
Previous 10,025,151
-0.0%
Holding current value
$31.8 Million
Previous $19 Million
36.85%
% of portfolio
0.12%
Previous 0.09%
Shares
6 transactions
Others Institutions Holding CMPX
# of Institutions
102Shares Held
101MCall Options Held
18.2KPut Options Held
2.51M-
Orbimed Advisors LLC San Diego, CA15.2MShares$48.2 Million1.41% of portfolio
-
Tang Capital Management LLC San Diego, CA13.5MShares$42.8 Million2.1% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.15MShares$22.7 Million0.64% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$21 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.04MShares$19.2 Million3.33% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $321M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...